COVID-19 UPDATE: All elective surgeries and procedures are cancelled until further notice. Please see our latest visitor policy. If you think you may have been exposed or have symptoms, please call your provider before visiting one of our locations. For more information, please visit our online COVID-19 Information Center or call the Montefiore-Einstein COVID-19 Hotline: 1-844-444-CV19 (1-844-444-2819).

ACTUALIZACIÓN SOBRE EL COVID-19: Todas las cirugías y operaciones quedan canceladas hasta nuevo aviso. Lea nuestras nuevas normas para visitas. Si cree que podría haber estado en contacto con la enfermedad o si presenta síntomas, por favor llame a su proveedor antes de acudir a cualquiera de nuestros centros. Más información en nuestro Centro de Información en Línea sobre el COVID-19 o llamando a la línea informativa Montefiore-Einstein de COVID-19: 1-844-444-CV19 (1-844-444-2819).

Pre-Implantation Genetic Diagnosis (PGD)
Home >  OB/GYN & Women's Health >  Services and Treatments >  Infertility - Reproductive Medicine >  Treatments and Procedures >  Pre-Implantation Genetic Diagnosis (PGD)
Print

OB/GYN & Women's Health

Pre-Implantation Genetic Diagnosis (PGD)

Preimplantation Genetic Diagnosis (PGD) is an advanced genetic test conducted on three-day-old embryos conceived with IVF that is recommended to patients who are carriers of a genetic anomaly condition. The purposed is to identify the embryos not carrying familial single genes associated with dominant and recessive diseases such as: Huntington's disease, Cystic Fibrosis, Sickle Cell Anemia, or Muscular Dystrophy, in order to avoid, or at least greatly reduce the risk of transmitting those genes to children.

Once the embryos are created amidst the IVF cycle, the embryologist removes one or two cells from each that are then tested for abnormal genes and chromosomes. The healthy cells are then transferred to the uterus.

PDG may also be used as an effective tool for women with a history of recurrent miscarriages. Since only embryos that do not contain abnormalities are selected for the transfer, the chance of a miscarriage - and birth defects, are greatly reduced.